Effect of Renal Failure and Hemodialysis on Aminocaproic Acid Plasma Concentrations

Abstract

Get full access to this article

View all access options for this article.

References

Keucher

Solow

Metaxas

Campbell

. Gas-chromatographic determination of an antifibrinolytic drug, ∈-aminocaproic acid. Clin Chem 1976; 22: 806–9.

McNicol

Fletcher

Alkjaersig

Sherry

The absorption, distribution, and excretion of 6-aminocaproic acid following oral or intravenous administration to man. J Lab Clin Med 1962; 59: 15–24.

Dvorchik

Katlic

Hayes

Eyster

. Effect of probenecid on the kinetics of epsilon-aminocaproic acid. Clin Pharmacol Ther 1980; 28: 223–8.

Frederiksen

Bowsher

Ruo

, Kinetics of epsilon-aminocaproic acid distribution, elimination, and antifibrinolytic effects in normal subjects. Clin Pharmacol Ther 1984; 35: 387–93.

Naeye

. Thrombotic state after a hemorrhagic diathesis, a possible complication of therapy wth epsilon-aminocaproic acid. Blood 1962; 19: 694–701.

Fish

Pancorbo

Berkseth

Pharmacokinetics of epsilon-aminocaproic acid during peritoneal dialysis. J Neurosurg 1981; 54: 736–9.

Gibson

. Problems in designing hemodialysis drug studies. Pharmacotherapy 1985; 5: 23–9.

Adams

Jr Nibbelink

Torner

Sahs

. Antifibrinolytic therapy in patients with aneurysmal subarachnoid hemorrhage: A report of the cooperative aneurysm study. ArchNeurol 1981; 38: 25–9.

Gibson

. Influence of renal disease on pharmacokinetics. In: Evans

Schentag

Jusko

, eds. Applied pharmacokinetics. 2nd ed. Spokane, WA: Applied Therapeutics, 1986: 83–115.